Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.62 - $0.86 $22,647 - $31,414
36,529 Added 4.34%
878,543 $632,000
Q4 2023

Feb 13, 2024

BUY
$0.7 - $1.31 $8,548 - $15,997
12,212 Added 1.47%
842,014 $715,000
Q3 2023

Nov 13, 2023

BUY
$1.25 - $3.0 $56,357 - $135,258
45,086 Added 5.75%
829,802 $1.14 Million
Q2 2023

Aug 11, 2023

BUY
$1.73 - $2.79 $702,251 - $1.13 Million
405,926 Added 107.16%
784,716 $1.98 Million
Q1 2023

May 15, 2023

BUY
$1.43 - $4.24 $40,659 - $120,555
28,433 Added 8.12%
378,790 $859,000
Q4 2022

Feb 13, 2023

BUY
$1.31 - $2.62 $17,720 - $35,440
13,527 Added 4.02%
350,357 $490,000
Q3 2022

Nov 14, 2022

BUY
$1.64 - $2.48 $440,723 - $666,460
268,734 Added 394.64%
336,830 $666,000
Q4 2021

Feb 11, 2022

BUY
$5.55 - $18.46 $377,932 - $1.26 Million
68,096 New
68,096 $382,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.